25N-NBOMe

25N-NBOMe
Clinical data
Other names	2C-N-NBOMe; NBOMe-2C-N
Drug class	Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code	None;
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); UK: Class A;
Identifiers
	IUPAC name 2-(2,5-dimethoxy-4-nitrophenyl)-N-[(2-methoxyphenyl)methyl]ethan-1-amine;
CAS Number	1354632-03-3;
PubChem CID	118536028;
ChemSpider	52085577;
UNII	0G7SSW2N0S;
CompTox Dashboard (EPA)	DTXSID501014186 ;
Chemical and physical data
Formula	C18H22N2O5
Molar mass	346.383 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC1=C(CCNCC2=C(OC)C=CC=C2)C=C(OC)C([N+]([O-])=O)=C1;
	InChI InChI=1S/C18H22N2O5/c1-23-16-7-5-4-6-14(16)12-19-9-8-13-10-18(25-3)15(20(21)22)11-17(13)24-2/h4-7,10-11,19H,8-9,12H2,1-3H3; Key:TXCKTIBHURMASQ-UHFFFAOYSA-N;

25N-NBOMe, also known as 2C-N-NBOMe or NBOMe-2C-N, is a derivative of the hallucinogen 2C-N. The pharmacological properties of 25N-NBOMe have not been described in the scientific literature, but it is believed to act in a similar manner to related compounds such as 25I-NBOMe and 25C-NBOMe, which are potent agonists at the 5HT_2A receptor. 25N-NBOMe has been sold as a street drug and has only been described in the literature in terms of identification by forensic analysis.